Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
Economist Podcasts - Babbage: BioNTech's founder on the future of mRNA technology

Babbage: BioNTech's founder on the future of mRNA technology

01/04/23 • 37 min

Economist Podcasts

Since covid-19 emerged three years ago, mRNA vaccines have taken the world by storm. How will they keep up with new variants of the coronavirus, and where does the mRNA revolution go from here?


Natasha Loder, The Economist’s health policy editor, talks to Ugur Sahin, the co-founder of BioNTech, whose covid vaccine changed the course of the pandemic. They consider the development of a universal coronavirus vaccine, and the other infectious diseases that will be targeted by mRNA jabs. Plus, the immunologist explains how mRNA technology can treat illnesses such as cancer, and his expectations for the technology in 2023. Alok Jha hosts.


For full access to The Economist’s print, digital and audio editions, subscribe at economist.com/podcastoffer and sign up for our weekly science newsletter at economist.com/simplyscience.



Hosted on Acast. See acast.com/privacy for more information.

plus icon
bookmark

Since covid-19 emerged three years ago, mRNA vaccines have taken the world by storm. How will they keep up with new variants of the coronavirus, and where does the mRNA revolution go from here?


Natasha Loder, The Economist’s health policy editor, talks to Ugur Sahin, the co-founder of BioNTech, whose covid vaccine changed the course of the pandemic. They consider the development of a universal coronavirus vaccine, and the other infectious diseases that will be targeted by mRNA jabs. Plus, the immunologist explains how mRNA technology can treat illnesses such as cancer, and his expectations for the technology in 2023. Alok Jha hosts.


For full access to The Economist’s print, digital and audio editions, subscribe at economist.com/podcastoffer and sign up for our weekly science newsletter at economist.com/simplyscience.



Hosted on Acast. See acast.com/privacy for more information.

Previous Episode

undefined - We need to balk about Kevin: Congress opens in chaos

We need to balk about Kevin: Congress opens in chaos

Republican control of America’s House of Representatives began in chaos: they failed to elect a speaker, the first time in a century that’s happened. China’s fishing fleet is the world’s largest—and a look at the thinning bounty from West Africa’s waters reveals its effects. And why the theft of catalytic converters is soaring in America. For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/intelligenceoffer


Hosted on Acast. See acast.com/privacy for more information.

Next Episode

undefined - Silva’s mettle: Brazil’s newish president

Silva’s mettle: Brazil’s newish president

Our Brazil correspondent surveys the state of the country, as Lula assumes the presidency precisely 20 years after his first inauguration. We ask why America’s armed forces are facing recruitment struggles not seen since the Vietnam War. And as Benedict XVI’s funeral begins, our obituaries editor reflects on his papacy. For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/intelligenceoffer


Hosted on Acast. See acast.com/privacy for more information.

Episode Comments

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/economist-podcasts-192/babbage-biontechs-founder-on-the-future-of-mrna-technology-27181175"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to babbage: biontech's founder on the future of mrna technology on goodpods" style="width: 225px" /> </a>

Copy